SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Zheng S. Lilly)
 

Sökning: WFRF:(Zheng S. Lilly) > (2005-2009) > Inherited variation...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004216naa a2200433 4500
001oai:DiVA.org:mdh-40710
003SwePub
008180906s2007 | |||||||||||000 ||eng|
009oai:DiVA.org:umu-2505
009oai:prod.swepub.kib.ki.se:115870696
024a https://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-407102 URI
024a https://doi.org/10.1158/1078-0432.CCR-07-06692 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-25052 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1158706962 URI
040 a (SwePub)mdhd (SwePub)umud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Lindstrom, Sarau Umeå universitet,Onkologi4 aut
2451 0a Inherited variation in hormone-regulating genes and prostate cancer survival
264 1a Umea Univ, Dept Radiat Sci Oncol, SE-90185 Umea, Sweden. Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden. Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden. Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA. Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27109 USA.b AMER ASSOC CANCER RESEARCH,c 2007
338 a print2 rdacarrier
520 a Purpose: Hormonal manipulation is the mainstay treatment of prostate cancer, notably in advanced stages. Despite initial favorably response, the cancer eventually develops hormone resistance resulting in disease progression and death. However, little is known about genetic determinants of disease progression and prostate cancer-specific death. Experimental Design: We analyzed a population-based cohort comprising 2,761 men diagnosed with prostate cancer from March 2001 to October 2003 and with complete follow-up through July 2006. During a median follow-up time of 3.8 years, a total of 300 men had died from prostate cancer. We genotyped 23 haplotype tagging single nucleoticle polymorphisms in the genes AR, CYP17, and SRD5A2 and used Cox proportional hazards analyses to quantify associations between genotype and risk of dying from prostate cancer. Results: The variant 'A': allele of an AR promoter single nucleoticle polymorphism, rs17302090, was borderline associated with a 50% increased risk of dying from prostate cancer (95% confidence interval, 1.0-2.3; P = 0.07). This finding was more pronounced in patients who received hormonal therapy as primary treatment at diagnosis (hazard ratio, 19; 95% confidence interval, 1.3-2.9; P = 0.007). We did not identify any associations between CYP17 or SRD5A2 variation and prostate cancer-specific death. Conclusions: Our results suggest that inherited genetic variation in the androgen receptor gene affects hormonal treatment response and ultimately prostate cancer death.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Hälsovetenskap0 (SwePub)3032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Health Sciences0 (SwePub)3032 hsv//eng
700a Adami, Hans-Olovu Karolinska Institutet4 aut
700a Bälter, Katarina Augustssonu Karolinska Institutet4 aut0 (Swepub:mdh)kbr01
700a Xu, Jianfeng4 aut
700a Zheng, S. Lilly4 aut
700a Stattin, Paeru Umeå universitet,Urologi och andrologi4 aut
700a Gronberg, Henriku Karolinska Institutet4 aut
700a Wiklund, Fredriku Karolinska Institutet4 aut
710a Umeå universitetb Onkologi4 org
773t Clinical Cancer Researchd Umea Univ, Dept Radiat Sci Oncol, SE-90185 Umea, Sweden. Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden. Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden. Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA. Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27109 USA. : AMER ASSOC CANCER RESEARCHg 13:17, s. 5156-5161q 13:17<5156-5161x 1078-0432x 1557-3265
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:mdh:diva-40710
8564 8u https://doi.org/10.1158/1078-0432.CCR-07-0669
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-2505
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:115870696

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy